Data sharing a a new era for research funded by the US Government

15 November 2023 - In January 2023, the NIH implemented its new Data Management and Sharing Policy.  ...

Read more →

How a controversial US drug policy could be harming cancer patients worldwide

9 August 2023 - The FDA’s accelerated approval process was designed to help people access life saving drugs.  ...

Read more →

How industrial policy could accelerate innovation in the life sciences

8 August 2023 - The US is expanding public investment in the technology-based industries, including the life sciences, in a move ...

Read more →

Novel Alzheimer disease treatments and reconsideration of US pharmaceutical reimbursement policy

17 July 2023 - While donanemab appears to be among the first therapies to demonstrate measurable clinical benefit for Alzheimer's disease, ...

Read more →

A priority review voucher program to fuel generic drug development

6 July 2023 - Millions of Americans report that they are unable to fill their prescriptions or are not taking their ...

Read more →

A review of labeling based on patient reported outcome endpoints for new oncology drugs approved by the EMA (2017-2021)

9 June 2023 - A review of new oncology indications approved by the EMA for 2012-2016 showed that 33% of new ...

Read more →

State of the Union highlights America’s awkward conversation on financing the development of new medicines

9 February 2023 - Science, medicine, health care, and paying for medicines featured prominently in President Joe Biden’s State of ...

Read more →

Prescription drug policy, 2022 and 2023: the year in review and the year ahead

9 January 2023 - This past year featured many significant developments in the prescription drug policy area, most notably the passage ...

Read more →

Amazon versus Apple: only one will rewrite the rules of health care

29 August 2022 - Big tech has had a surprisingly small impact on U.S. healthcare, so far. ...

Read more →

EMA adopts first list of critical medicines for COVID-19

8 June 2022 - On 7 June 2022, the EMA’s Medicines Shortages Steering Group adopted the list of critical medicines for ...

Read more →

Medicago, Philip Morris and Health Canada: a predictable and avoidable fiasco

22 March 2022 - Health groups urge the Federal government to pressure Medicago to align its approach with that of ...

Read more →

Three doses to be ‘up to date’ as national cabinet prepares for winter waves

10 February 2022 - Top Australian health officials now say people need a third coronavirus vaccine dose to be considered up ...

Read more →

ATAGI update following weekly COVID-19 meeting – 9 February 2022

10 February 2022 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 9 ...

Read more →

Canada's national strategy for drugs for rare diseases needs a holistic approach

8 December 2021 - International report summarises drugs for rare disease best practices and recommendations. ...

Read more →

Pharmaceutical industry backs workplace vaccinations

5 October 2021 - Medicines Australia strongly recommends full COVID-19 vaccinations for the health and safety and protection of all ...

Read more →